Because children’s brains are growing, they are more susceptible to interference with glucose production and metabolic breakdown, which has several adverse effects. Glucose in the brain is essential to its proper functioning, as the brain requires glucose to incite and feed brain cells. Read more
Many people who have been diagnosed with type 1 diabetes are overwhelmed by the daily physical and mental challenges of managing the condition. This can result in “diabetes burnout,” a dangerous condition where patients are so overwhelmed they neglect to manage their insulin, glucose testing and food choices adequately. Read more
A precision medicine treatment has led to the reversal of a case of type 1 diabetes in a male patient, says a study published in the New England Journal of Medicine. The researchers found the patient had a harmful mutation in a gene called STAT1, and treated the patient with a drug that could inhibit […]
Adolescents and young adults age 17-23 who have type 1 diabetes are at high risk for negative health outcomes, including poor glycemic control, as they move from pediatric and parental care to independent self-care skills and preparation for adult diabetes care. Researchers are examining how improved communication between young people and health care providers can […]
An international team of experts have laid out the world’s first standard guidance on how people with diabetes can use modern glucose monitoring devices to help them exercise safely. The guidance can be used by healthcare professionals around the world to help people with type 1 diabetes. Read more
Doctors know that a certain percentage of people with type 1 diabetes will experience what’s called a “partial remission,” after being diagnosed and started on insulin therapy. Partial remission is a period of time in which the patient’s beta–cell function will temporarily be restored. Researchers are seeking to understand what determines which patients will experience this partial […]
A new data modelling study says that the average person with type 1 diabetes in the UK today will live almost eight years less than an average person who does not have diabetes, while those with type 2 diabetes will live almost 2 years less than a person without type 2. Read more
Type 1 diabetes can affect young patients in many ways. A recent study found that exposure to glycemic extremes can have a negative impact on healthy brain development and cognitive function, including spatial working memory, in teenagers. Read more
The coronavirus pandemic may have delayed diabetes diagnoses for many children with type 1, according to Italian researchers studying how diabetes diagnoses in 2020 have compared to historic data. Read more
A new study published in the New England Journal of Medicine found that an artificial pancreas system, using a continuous glucose monitoring (CGM) device and a separate insulin pump, was safe and beneficial in children with type 1 diabetes who were as young as six years of age. Read more
People with diabetes are at higher risk for complications of COVID-19, and good diabetes management is key for maximizing health and reducing risk. But for many with type 1, obtaining insulin is a challenge due to job and health insurance losses in the pandemic. Read more
For pregnant women with type 1 diabetes, their maternal glucose levels play a large role in determining fetal growth. Continuous glucose monitoring (CGM) allows expecting mothers to assess the changes in their blood glucose levels. Read more
Do-it-yourself artificial pancreas systems (DIYAPS) were developed by members of the diabetes community to offer a solution to type 1 diabetes patients who can’t access or afford other tech systems. Read more
Researchers have used artificial intelligence (AI) to develop an algorithm that gives people weekly guidance on managing their type 1 diabetes, based on data from a continuous glucose monitor, insulin pens, and a wearable device to monitor physical activity. The algorithm also uses a smartphone app called DailyDose. Read more
Balancing blood glucose levels during (and after) exercise with type 1 diabetes is key if you want to be successful at being physically active as an insulin user, and want to prevent hypoglycemia or hyperglycemia during exercise. Diabetes exercise expert Dr. Sheri Colberg shares some tips for managing insulin, food, and exercise. Read more
Teplizumab may become the first antibody commercially available that can halt or delay the progression of type 1 diabetes. Researchers have found that a single 14-day infusion of teplizumab leads to a median 3-year delay in type 1 diabetes onset in high-risk individuals. Read more
Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the […]
Researchers continue examining the relationship between diabetes and coronavirus. In a new study looking specifically at type 1 diabetes, they found that about half the people in the study with type 1 and COVID-19 had abnormally high blood sugar, which demonstrates how COVID-19 can complicate blood sugar control. Read more
Researchers at Oregon Health & Science University have developed a new method to help people with type 1 diabetes manage their glucose levels. The system uses artificial intelligence and automated monitoring, and generates recommendations that were similar to those from endocrinologists, the researchers say. Read more
A new study found that out-of-pocket costs for Americans who have type 1 diabetes average $2,500 a year. And 8% of patients pay more than $5,000 out-of-pocket, perhaps due to high-deductible health insurance plans or significant medical needs. Insulin accounts for only 18% of this spending, with insulin pumps, syringes, CGMs and other supplies making […]